Skip to content

AHC International Media Library

Alternating Hemplegia of Childhood and ATP1A3 disorders

  • Interviews
  • Home Videos
  • News
  • Associations
  • Documentaries
  • Presentations
  • Contact
  • About AHCIM
  • Articles
  • Toggle search form

Kenneth Silver – Why do not all AHC Patients have the ATP1A3 mutation? 2/3

Posted on November 12, 2018November 15, 2018 By siggi

Dr. Silver answers questions from parents that were not able to join the ATP1A3 symposium in Chicago 2018

Dr. Kenneth Silver, Associate Professor, child neurology
Dr Silver is an AHC researcher and one of very few AHC specialists in the world.
Shriners Hospitals for Children Chicago, USA
Kenneth Silver, M.D., is a pediatric neurologist at Shriners Hospitals for Children — Chicago and co-director of the muscular dystrophy MDA-affiliated clinic at Shriners Hospitals for Children — Chicago.
He is board certified in neurology and pediatric neurology from the American Board of Psychiatry and Neurology, Inc.
As a pediatric neurologist he provides care for patients and investigates diseases of the nervous system, which includes the brain, spinal cord and muscles.

Interviews Tags:atp1a3, kenneth silver, questions

Post navigation

Previous Post: Dr. Kenneth Silver at the ATP1A3 symposium in Chicago 1/3
Next Post: Kenneth Silver – Improving quality of life for AHC Patients? 3/3

Related Posts

Thomas Holm – London 2016 Interviews
Rick Simpson – Would cbd oil help AHC? Interviews
Plymouth Family Raises Awareness for Rare Disease Interviews
Elisa de Grandis – London 2016 Interviews
Kevin Ess – London 2016 Interviews
Prof. Arn M.J.M. van den Maagdenberg – Lunteren 2014 Interviews

Copyright © 2026 AHC International Media Library.

Powered by PressBook Masonry Dark